As a team, we developed targeted recommendations aimed at accelerating the integration of ML+CSVD into clinical practice.
13.08.2025 11:29 β π 1 π 0 π¬ 0 π 0@joseabernal.bsky.social
Assistant Professor | FAU | CSVD & Neuroimaging | He/him
As a team, we developed targeted recommendations aimed at accelerating the integration of ML+CSVD into clinical practice.
13.08.2025 11:29 β π 1 π 0 π¬ 0 π 0In need of improvement: Serious methodological issuesβsuch as inconsistent reporting, limited testing of generalisability, and other potential biasesβremain common and continue to hinder broader adoption.
13.08.2025 11:29 β π 1 π 0 π¬ 1 π 0Positive: There is growing interest in incorporating CSVD markers into ML models for classifying neurodegenerative diseases, and current performance indicates that this approach merits further investigation.
13.08.2025 11:29 β π 0 π 0 π¬ 1 π 0We carried out a systematic review and meta-analysis to examine the use of neuroimaging CSVD markers in machine learningβbased diagnosis and prognosis of cognitive impairment and dementia, while also identifying methodological trends over time and barriers to clinical translation.
13.08.2025 11:29 β π 2 π 0 π¬ 2 π 0π¨ Hot off the press! π¨
Our systematic review and meta-analysis on ML+CSVD for dementia diagnosis and prognosis has been published! An international collaboration, featuring @Valerie Lohner
@oparent.bsky.social
@helenagellersen.bsky.social
and many others.
doi.org/10.1186/s131...
@dzne.science
π’ Hot off the press! π’
Want to show that healthcare AI really works in everyday settings? Large-scale, multi-site studies are a powerful path forward. Iβm thrilled to have joined this effort as part of the Colombian collaborator team.
doi.org/10.1038/s414...
@dzne.science
Take home π message:
Cerebrovascular and ageing-related atrophic changes are interrelated and shape cognitive trajectories. Trajectories may nonetheless be modified for the better by managing cerebrovascular and mental health while fostering cognitive engagement.
(B) WMH progression and ageing-related atrophy were independently associated with changes in cognitive performance, underscoring their relevance for brain maintenance.
(C) Neuroticism, depression, and low cognitive engagement predicted worse domain-specific trajectories.
(A) WMH not only co-occur with medial temporal lobe atrophy but may also contribute to and accelerate its progression. We observed this coupling also in a prior study (doi.org/10.1186/s131...). This finding suggests that preserving microvasculature may reduce vulnerability to neurodegeneration.
17.06.2025 21:26 β π 1 π 0 π¬ 1 π 0Using four-year data from 543 cognitively unimpaired participants from the DELCODE study and latent growth curve modelling, we examined the co-evolution of white matter hyperintensities (WMH), medial temporal lobe to ventricle ratio, and cognitive performance.
17.06.2025 21:26 β π 1 π 0 π¬ 1 π 0π¨New preprint π¨
TL;DR Supporting cerebrovascular and mental health, along with staying cognitively engaged, may help preserve brain function and delay cognitive decline and dementia.
@dzne.science
I had no clue you were working on CSVD!!!
23.05.2025 10:26 β π 1 π 0 π¬ 1 π 0π’ Habemus preprint π’
Our systematic review and meta-analysis on ML+vascular neuroimaging for dementia diagnosis and prognosis is out! Fantastic collaboration with @ValerieLohner, @oparent.bsky.social @helenagellersen.bsky.social and many others! Check it out! @dzne.science